Senate hearing on antipsychotic use in nursing homes to be held today

Share this article:

The Senate Special Committee on Aging will hold a hearing today about the use of antipsychotics in nursing homes.

The hearing, titled “Overprescribed: The Human and Taxpayers' Costs of Antipsychotics in Nursing Homes,” is scheduled for 2 p.m. ET, and will be held in the Dirksen Senate Office Building, Washington, D.C.

Sen. Herb Kohl (D-WI) who is the chairman of the committee, has played an active role in investigating proper prescribing practices of antipsychotics in nursing homes. Antipsychotic medications, such as Seroquel, Zyprexa, Risperdal and Abilify, are often administered off-label to treat agitated and aggressive behaviors in dementia care residents.

Panelists at the hearing will be Daniel R. Levinson, Inspector General, U.S. Department of Health and Human Services; Patrick Conway, M.D., director and chief medical officer, Centers for Medicare & Medicaid Services; Jonathan Evans, M.D. president, American Medical Directors Association; Tom Hlavacek, executive director, Alzheimer's Association of Southeast Wisconsin; Toby Edelman, senior policy attorney, Center for Medicare Advocacy; Cheryl Phillips, M.D., senior vice president of advocacy, LeadingAge.

Click here Wednesday for a live stream of the hearing.

Share this article:

More in News

Involving nursing assistants with decisions may result in higher quality, study finds

Empowering nursing assistants and family members of nursing home residents in decision-making results improved service, a new study finds.

Also in the news for July 28, 2014 . . .

Nursing home aide accused of choking a resident....Monitoring pulse after stroke may prevent another stroke...Slow walking speed may predict dementia

Site-neutral payments likely to move forward, experts believe

Site-neutral payments likely to move forward, experts believe

As the Centers for Medicare & Medicaid Services and the Medicare Payment Advisory Commission evaluate site-neutral payments, a new brief from Health Affairs and the Robert Wood Johnson Foundation explores ...